| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8222727 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 6 Pages |
Abstract
In randomized trials for resectable gastric cancer, adjuvant RT provides an approximately 20% improvement in both DFS and OS. Available data do not reveal a subgroup of patients that does not benefit from adjuvant RT. Further study is required to optimize the implementation of adjuvant RT for gastric cancer with regard to patient selection and integration with systemic therapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Nitin MD, Madhur K. MD, Santiago MD, Andreas MD, Wolfgang PhD, Timothy J. MD, Shalom MD, Chandan MD, PhD,